POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE ANALYSES TO INFORM DOSING OF ICATIBANT IN PEDIATRIC PATIENTS WITH HEREDITARY ANGIOEDEMA.

被引：0
|
作者：
Wang, Y. [1 ]
Jomphe, C. [2 ]
Marier, J. [2 ]
Martin, P. [1 ]
机构：
[1] Shire, Lexington, MA USA
[2] Certara, West Windsor Township, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-064
引用
收藏
页码：S95 / S96
页数：2
相关论文
共 50 条
  • [21] Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses
    Majid, Oneeb
    Reyderman, Larisa
    Ferry, Jim
    Hussein, Ziad
    NEUROLOGY, 2019, 92 (15)
  • [22] Population pharmacokinetics and exposure-response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer
    Cosson, Valerie F.
    Ng, Vivian W.
    Lehle, Michaela
    Lum, Bert L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 737 - 747
  • [23] Population pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer
    Nguyen, Jenny-Hoa
    Epling, Daniel
    Dolphin, Nancy
    Paccaly, Anne
    Conrado, Daniela
    Davis, John D.
    Al-Huniti, Nidal
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (11): : 1458 - 1471
  • [24] Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: Searching for exposure-response relationships
    Soy, D
    Aweeka, FT
    Church, JA
    Cunningham, CK
    Palumbo, P
    Kosel, BW
    Sheiner, LB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (06) : 569 - 580
  • [25] Pharmacokinetics, Pharmacodynamics and Exposure-Response Analyses of Ocrelizumab in Patients With Multiple Sclerosis
    Kletzl, Heidemarie
    Gibiansky, Ekaterina
    Petry, Claire
    Mercier, Francois
    Guenther, Andreas
    Wang, Qing
    Model, Fabian
    Kappos, Ludwig
    Hauser, Stephen
    NEUROLOGY, 2019, 92 (15)
  • [26] Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey
    Andresen, Irmgard
    Longhurst, Hilary
    Aberer, Werner
    Bouillet, Laurence
    Caballero, Teresa
    Grumach, Anete S.
    Maurer, Marcus
    Botha, Jaco
    Zanichelli, Andrea
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB44 - AB44
  • [27] Population Pharmacokinetics and Exposure-Response Analyses of an MDM2 Inhibitor Milademetan
    Kang, Dongwoo
    Kumar, Prasanna
    Zernovak, Oleg
    Song, Saeheum
    Xiong, Yuan
    Bergsma, Tim
    Lovern, Mark
    Yin, Ophelia
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S24 - S24
  • [28] Population Pharmacokinetics and Exposure-Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Kowalski, Ken
    Sandborn, William J.
    Feagan, Brian
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1336 - 1355
  • [29] Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes
    Petri, Kristin C. C.
    Hale, Paula M.
    Hofman, Paul L.
    Jacobsen, Lisbeth, V
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (10): : 1289 - 1292
  • [30] Population Pharmacokinetics, Efficacy Exposure-Response Analysis
    Chan, Phyllis
    Yu, Jiajie
    Chinn, Leslie
    Prohn, Marita
    Huisman, Jan
    Matzuka, Brett
    Hanley, William
    Tuckwell, Katie
    Quartino, Angelica
    PHARMACEUTICAL RESEARCH, 2020, 37 (02)
12345